semaglutide fda news alerts health care providers, compounders and patients of dosing errors associated with compounded injectable products Semaglutide FDA Approval vs Compounded

Second, a 2023 study published in Nature Medicine found that elevated erythritol levels in the blood were associated with a significantly increased risk of major cardiovascular events including heart attack and stroke across three independent patient cohorts a finding significant enough that the researchers called for authorities to re-evaluate existing safety guidelines

These drugs offer dual benefits, improving glycemic control while boosting weight loss, which makes them a preferred option in managing both type 2 diabetes and obesity

Theres also the Baader-Meinhof phenomenon to consider, known by its more familiar names frequency bias or frequency illusion

"Often in managing weight, there's so much stigma and bias from both the clinician side and the patient side that often people's brains want to try to tell them that they can outsmart the system," she says

While this can lead to meaningful weight loss and better blood glucose control, it can also trigger changes that make you feel dizzy or off balanceespecially early in treatment